Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.

Bibliografische gegevens
Hoofdauteurs:	Chahal, H, Ansorge, O, Karavitaki, N, Leontiou, C, Carlsen, E, Wass, J, Grossman, AB, Korbonits, M
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2011

Gelijkaardige items

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
door: Chahal, H, et al.
Gepubliceerd in: (2010)

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
door: Chahal, H, et al.
Gepubliceerd in: (2012)

Acromegaly: Treatment with somatostatin analogs
door: Karavitaki, N, et al.
Gepubliceerd in: (2005)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
door: Ur, E, et al.
Gepubliceerd in: (1992)

The role of somatostatin analogues in the treatment of neuroendocrine tumours.
door: Grozinsky-Glasberg, S, et al.
Gepubliceerd in: (2008)

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.
door: Larkin, S, et al.
Gepubliceerd in: (2013)

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
door: Grozinsky-Glasberg, S, et al.
Gepubliceerd in: (2008)

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
door: Karavitaki, N, et al.
Gepubliceerd in: (2005)

Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas.
door: Larkin, S, et al.
Gepubliceerd in: (2014)

Increased population risk of AIP-related acromegaly and gigantism in Ireland.
door: Radian, S, et al.
Gepubliceerd in: (2016)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
door: Jenkins, P, et al.
Gepubliceerd in: (2000)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
door: Kaltsas, G, et al.
Gepubliceerd in: (2005)

Antiangiogenic effects of somatostatin analogues.
door: García de la Torre, N, et al.
Gepubliceerd in: (2002)

AIP, a Protein Mutated in Familial Acromegaly, Plays a Role in the Regulation of Cell Proliferation and Shows Cell-Type Specific Subcellular Localisation
door: Leontiou, C, et al.
Gepubliceerd in: (2009)

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
door: Fernandez, A, et al.
Gepubliceerd in: (2008)

Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
door: Kaltsas, G, et al.
Gepubliceerd in: (2002)

Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
door: Hubina, E, et al.
Gepubliceerd in: (2006)

Pegvisomant: a new treatment modality for acromegaly.
door: Karavitaki, N, et al.
Gepubliceerd in: (2004)

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
door: Ur, E, et al.
Gepubliceerd in: (1993)

Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro.
door: Orkin, R, et al.
Gepubliceerd in: (2003)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
door: Arnold, JR, et al.
Gepubliceerd in: (2009)

The Pathogenic Role of AIP Mutations - The Importance of the Integration of Clinical, Experimental and Modeling Data on Advising Patients and Their Families with Pituitary Adenoma Predisposition.
door: Trivellin, G, et al.
Gepubliceerd in: (2010)

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
door: King, C, et al.
Gepubliceerd in: (1993)

Acute octreotide suppression test (100 mu g sc): a valuable tool for predicting the long-term response to the long-acting somatostatin analogs in patients with active acromegaly
door: Karavitaki, N, et al.
Gepubliceerd in: (2005)

Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
door: Preda, V, et al.
Gepubliceerd in: (2014)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
door: Grossman, A, et al.
Gepubliceerd in: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
door: Grossman, A, et al.
Gepubliceerd in: (1986)

GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.
door: Ross, R, et al.
Gepubliceerd in: (1987)

New treatments for acromegaly.
door: Wass, J, et al.
Gepubliceerd in: (1998)

Hypercalcaemia in acromegaly is not always due to men-1
door: Zabuliene, L, et al.
Gepubliceerd in: (2005)

AIP mutation in pituitary adenomas in the 18th century and today.
door: Chahal, H, et al.
Gepubliceerd in: (2011)

The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
door: Hindmarsh, P, et al.
Gepubliceerd in: (1991)

Acromegaly, colonic polyps and carcinoma.
door: Jenkins, P, et al.
Gepubliceerd in: (1997)

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
door: Karavitaki, N, et al.
Gepubliceerd in: (2006)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
door: Wass, J
Gepubliceerd in: (1997)

Long-term effects of radiotherapy for acromegaly.
door: Wass, J
Gepubliceerd in: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
door: Wass, J
Gepubliceerd in: (2003)

The pathology of median neuropathy in acromegaly.
door: Jenkins, P, et al.
Gepubliceerd in: (2000)

Guidelines for acromegaly management.
door: Melmed, S, et al.
Gepubliceerd in: (2002)

Glucose-induced changes in somatostatin-14 and somatostatin-28 released from rat hypothalamic fragments 'in vitro'.
door: Lengyel, A, et al.
Gepubliceerd in: (1984)